Literature DB >> 25368450

An Examination of the First Oxford House in the UK: A Preliminary Investigation.

John M Majer1, Kim Beers2, Leonard A Jason3.   

Abstract

An exploratory investigation was conducted to examine the implementation of the first self-run, communal-living setting based on the Oxford House model, in the United Kingdom (UK). A cross-sectional, mixed methods design was used to examine the Oxford House model's total abstinence approach to recovery from substance use disorders among residents (n = 7) living in the first Oxford House established in the UK. Several measures commonly used in addiction research and personal narratives were used to assess residents' response to Oxford House living. Findings suggest that the Oxford House model is a post-treatment intervention that meets the needs of individuals seeking an abstinence-based recovery from alcohol and/or drug dependence in the UK.

Entities:  

Keywords:  Abstinence; Oxford House; Personal Narratives; Recovery; Substance use disorders; United Kingdom

Year:  2014        PMID: 25368450      PMCID: PMC4215736          DOI: 10.3109/09687637.2013.876974

Source DB:  PubMed          Journal:  Drugs (Abingdon Engl)        ISSN: 0968-7637


  20 in total

1.  Sociability and susceptibility to the common cold.

Authors:  Sheldon Cohen; William J Doyle; Ronald Turner; Cuneyt M Alper; David P Skoner
Journal:  Psychol Sci       Date:  2003-09

2.  The Alcoholics Anonymous Affiliation Scale: development, reliability, and norms for diverse treated and untreated populations.

Authors:  K Humphreys; L A Kaskutas; C Weisner
Journal:  Alcohol Clin Exp Res       Date:  1998-08       Impact factor: 3.455

3.  Development and validation of the drug-taking confidence questionnaire: a measure of coping self-efficacy.

Authors:  S M Sklar; H M Annis; N E Turner
Journal:  Addict Behav       Date:  1997 Sep-Oct       Impact factor: 3.913

4.  Initial evidence for the reliability and validity of a "Lite" version of the Addiction Severity Index.

Authors:  John S Cacciola; Arthur I Alterman; A Thomas McLellan; Yi-Ting Lin; Kevin G Lynch
Journal:  Drug Alcohol Depend       Date:  2006-10-11       Impact factor: 4.492

5.  12-Step involvement among a U.S. national sample of Oxford House residents.

Authors:  John M Majer; Leonard A Jason; Joseph R Ferrari; Steve A Miller
Journal:  J Subst Abuse Treat       Date:  2011-02-24

6.  Categorical 12-step involvement and continuous abstinence at 2 years.

Authors:  John M Majer; Leonard A Jason; Darrin M Aase; Jocelyn R Droege; Joseph R Ferrari
Journal:  J Subst Abuse Treat       Date:  2012-04-11

7.  The need for substance abuse after-care: longitudinal analysis of Oxford House.

Authors:  Leonard A Jason; Margaret I Davis; Joseph R Ferrari
Journal:  Addict Behav       Date:  2006-07-14       Impact factor: 3.913

8.  A longitudinal analysis of psychiatric severity upon outcomes among substance abusers residing in self-help settings.

Authors:  John M Majer; Leonard A Jason; Carol S North; Joseph R Ferrari; Nicole S Porter; Bradley Olson; Margaret Davis; Darrin Aase; J Paul Molloy
Journal:  Am J Community Psychol       Date:  2008-09

9.  Optimism, abstinence self-efficacy, and self-mastery: a comparative analysis of cognitive resources.

Authors:  John M Majer; Leonard A Jason; Bradley D Olson
Journal:  Assessment       Date:  2004-03

10.  Community Involvement among Residents of Second-Order Change Recovery Homes.

Authors:  Leonard A Jason; Dan Schober; Bradley D Olson
Journal:  Aust Community Psychol       Date:  2008-06
View more
  2 in total

1.  Abstinence Self-Efficacy and Substance Use at 2 Years: The Moderating Effects of Residential Treatment Conditions.

Authors:  John M Majer; Hannah M Chapman; Leonard A Jason
Journal:  Alcohol Treat Q       Date:  2016-10-05

2.  Developing a Latent Coping Resources Factor for Recovery from Substance Use Disorder.

Authors:  Alexandra Porcaro; Rebecca Nguyen; Meghan Salomon-Amend; Jessica Chaparro; Leonard Jason
Journal:  Addict Res Theory       Date:  2020-08-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.